The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab-based induction chemoimmunotherapy and PD-L1 expression in locoregionally advanced HPV-associated oropharyngeal squamous cell carcinoma.
 
Ari Rosenberg
Stock and Other Ownership Interests - Galectin Therapeutics
Consulting or Advisory Role - EMD Serono; Nanobiotix
Research Funding - Sysmex
 
Alexander T. Pearson
Stock and Other Ownership Interests - Inovalon (I)
Consulting or Advisory Role - Abbvie; Ayala Pharmaceuticals; Elevar Therapeutics; Prelude Therapeutics
Research Funding - Abbvie (Inst); Kura Oncology (Inst)
 
Nishant Agrawal
No Relationships to Disclose
 
Aditya Juloori
Consulting or Advisory Role - Isoray
Research Funding - AstraZeneca
 
Tanguy Y. Seiwert
Honoraria - Merck; Nanobiotix
Consulting or Advisory Role - Innate Pharma; Merck; Nanobiotix; Regeneron; VIR Biotechnology
Research Funding - AstraZeneca Canada (Inst); Bristol Myers Squibb Foundation (Inst); Genentech (Inst); Merck (Inst); Nanobiotix (Inst)
 
Zhen Gooi
No Relationships to Disclose
 
Elizabeth A. Blair
No Relationships to Disclose
 
Evgeny Izumchenko
Consulting or Advisory Role - Ayala Pharmaceuticals; Prelude Therapeutics
Research Funding - Prelude Therapeutics (Inst)
 
Jeffrey Chin
No Relationships to Disclose
 
Daniel Ginat
No Relationships to Disclose
 
Mark Lingen
No Relationships to Disclose
 
Daniel J. Haraf
No Relationships to Disclose
 
Everett E. Vokes
Stock and Other Ownership Interests - Coordination Pharmaceuticals
Honoraria - Ascendis Pharma (I); AstraZeneca; BeiGene; BioNTech; EMD Serono; Genentech; GlaxoSmithKline; Lilly; Novartis; Radius Health (I); Takeda (I)
Consulting or Advisory Role - Ascendis Pharma (I); AstraZeneca; BeiGene; BioNTech; EMD Serono; Genentech; GlaxoSmithKline; Lilly; Novartis; Radius Health (I); Takeda (I)
Research Funding - Abbvie; Bristol-Myers Squibb; Celgene; Lilly (Inst); Novartis
Travel, Accommodations, Expenses - AstraZeneca; BeiGene; BioNTech; EMD Serono; Genentech; GlaxoSmithKline; Lilly; Novartis